About Microchips Biotech
Microchips Biotech is a company based in Lexington (United States) founded in 1999 by David H Koch was acquired by Daré Bioscience in November 2019.. Microchips Biotech has raised $118.61 million across 9 funding rounds from investors including Medtronic, Novartis and Teva Pharmaceuticals. The company has 10 employees as of December 31, 2022. Microchips Biotech operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Lexington, United States
- Employees 10 as on 31 Dec, 2022
- Founders David H Koch
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Microchips, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$118.61 M (USD)
in 9 rounds
-
Latest Funding Round
$18.65 M (USD), Series E
Jun 24, 2015
-
Investors
Medtronic
& 9 more
-
Employee Count
10
as on Dec 31, 2022
-
Acquired by
Daré Bioscience
(Nov 11, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Microchips Biotech
Microchips Biotech has successfully raised a total of $118.61M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $18.65 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series E — $18.6M
-
First Round
First Round
(17 Jun 2002)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2015 | Amount | Series E - Microchips Biotech | Valuation | Polaris Partners , Flybridge Capital Partners |
|
| Jun, 2015 | Amount | Series E - Microchips Biotech | Valuation |
investors |
|
| Jan, 2010 | Amount | Series D - Microchips Biotech | Valuation | InterWest Partners , Polaris Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Microchips Biotech
Microchips Biotech has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Novartis and Teva Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused venture capital firm
|
Founded Year | Domain | Location | |
|
Early-stage tech startups are funded by Flybridge Capital Partners.
|
Founded Year | Domain | Location | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Microchips Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Microchips Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Microchips Biotech Comparisons
Competitors of Microchips Biotech
Microchips Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Microchips Biotech
Frequently Asked Questions about Microchips Biotech
When was Microchips Biotech founded?
Microchips Biotech was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Where is Microchips Biotech located?
Microchips Biotech is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Is Microchips Biotech a funded company?
Microchips Biotech is a funded company, having raised a total of $118.61M across 9 funding rounds to date. The company's 1st funding round was a Series D of $16.5M, raised on Jun 17, 2002.
How many employees does Microchips Biotech have?
As of Dec 31, 2022, the latest employee count at Microchips Biotech is 10.
What does Microchips Biotech do?
Microchips Biotech develops microchip implants for drug delivery. Its platform technology is an implantable microchip that can be inserted in a physicians office under local anesthesia and can be activated or inactivated wirelessly. This microchip can then release preset doses of the device over months and years. Microchips has won a grant from the Bill and Melinda Gates Foundation to use its platform technology to develop an implantable contraceptive device for women with a life of 16 years. In addition, the company has a partnership with Teva to apply its drug delivery platform for Teva generics in the management of chronic diseases, like osteoporosis. Microchips was co-founded by MITs Robert Langer and Michael Cima. The technology can be used for therapies that require frequent, long-term dosing, or delivery via injection in diseases such as osteoporosis, diabetes, multiple sclerosis, pain management and several others.
Who are the top competitors of Microchips Biotech?
Microchips Biotech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Microchips Biotech's investors?
Microchips Biotech has 10 investors. Key investors include Medtronic, Novartis, Teva Pharmaceuticals, Daré Bioscience, and Polaris Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.